Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 3/20 | 0.35 |
| ▸ | KDR | P35968 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | PNMT | P11086 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL717055 | 0.85 | TDP2 (0.46) | NPC1LMNAMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL3443207 | 0.83 | ADORA2A (0.38) | ALDH1A1KDM4ENPC1LMNAMAPT | |
| SCHEMBL6571163 | 0.83 | MEN1 (0.38) | ALDH1A1KDM4ENPC1LMNAMAPT | |
| SCHEMBL313500 | 0.79 | PNMT (0.44) | ALDH1A1KDM4ENPC1LMNAMAPT | |
| SCHEMBL2965677 | 0.79 | ALDH1A1 (0.36) | ALDH1A1KDM4ENPC1LMNAMAPT | |
| SCHEMBL2974521 | 0.79 | KDM4E (0.36) | ALDH1A1KDM4ENPC1LMNAMAPT | |
| SCHEMBL217877 | 0.79 | ALDH1A1 (0.36) | ALDH1A1KDM4ENPC1LMNAMAPT | |
| SCHEMBL2974781 | 0.78 | KDM4E (0.35) | ALDH1A1KDM4ENPC1LMNAMAPT | |
| SCHEMBL1029595 | 0.77 | KDM4E (0.34) | ALDH1A1KDM4ENPC1LMNAMAPT | |
| SCHEMBL2972402 | 0.76 | KDM4E (0.33) | ALDH1A1KDM4ENPC1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1440 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115403580-B | Nitrogen-containing heterocyclic compound and application thereof | 宁波卢米蓝新材料有限公司 | 2024-04-30 | — | — | CN | claimed |
| US-20240083876-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2024-03-14 | — | — | US | claimed |
| CN-117417261-A | 2, 3-substituted naphthylamine derivative organic light-emitting compound and organic electroluminescent device | CMDL有限公司 | 2024-01-19 | — | — | CN | claimed |
| CN-114516803-B | Fused ring compound and application thereof | 宁波卢米蓝新材料有限公司 | 2024-01-09 | — | — | CN | claimed |
| CN-117304207-A | Compound containing phenoxazinooxazole structure and application thereof | 烟台九目化学股份有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-117247324-A | Fused ring compound and application thereof | 宁波卢米蓝新材料有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-117143058-A | Triarylamine compound and organic electroluminescent device thereof | 长春海谱润斯科技股份有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-116724020-A | Novel compound and organic light emitting device comprising the same | 株式会社LG化学 | 2023-09-08 | — | — | CN | claimed |
| CN-116655663-A | Boron-containing organic compound and organic electroluminescent device prepared from same | 江苏三月科技股份有限公司 | 2023-08-29 | — | — | CN | claimed |
| WO-2023085670-A1 | NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2023-05-19 | — | — | WO | claimed |
| US-7276567-B2 | Heterocyclic substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-10-02 | — | — | US | claimed |
| US-6921799-B1 | Olefin polymerization process | BOREALIS A/S (DK) | 2005-07-26 | — | — | US | claimed |
| CN-1157427-C | Polymerization method for olefrines | �����ɷ� | 2004-07-14 | — | — | CN | claimed |
| EP-0993478-B1 | OLEFIN POLYMERIZATION PROCESS | BOREALIS TECH OY (FI) | 2004-04-07 | — | — | EP | claimed |
| US-6245938-B1 | COMPOUND SUITABLE FOR USE BOTH AS DERIVATIZING GROUP FOR OPTICAL SEPARATION OF ENANTIOMERS AND AS PROTECTING GROUP FOR PREPARATION OF MISACYLATED TRNA | UNIVERSITY OF VIRGINIA PATENT FOUNDATION | 2001-06-12 | — | — | US | claimed |
| CN-1260807-A | Polymerization method for olefrines | BOREALL AS (DK) | 2000-07-19 | — | — | CN | claimed |
| EP-0993478-A1 | OLEFIN POLYMERIZATION PROCESS | BOREALIS A/S (DK) | 2000-04-19 | — | — | EP | claimed |
| WO-1998058001-A1 | OLEFIN POLYMERIZATION PROCESS | COCKBAIN, JULIAN (GB) | 1998-12-23 | — | — | WO | claimed |
| EP-0694041-A1 | A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING N-ALPHA-METHYLARGININE | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-01-31 | — | — | EP | claimed |
| WO-1994022911-A2 | A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING Nα-METHYLARGININE | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-10-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240083876-A1 | ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | SOD1, TERT, AOC2 | ALDH1A1 572/4885KDM4E 868/4885NPC1 3149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.